The role of klebsiella in Crohn's disease with a potential for the use of antimicrobial measures

International Journal of Rheumatology

Volumn 2013, Issue , 2013, Pages

  Rashid, Taha ^a   Ebringer, Alan ^a   Wilson, Clyde ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b King Edward VII Memorial Hospital   (Bermuda)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; BACTERIUM ANTIBODY; BIOLOGICAL PRODUCT; COLLAGEN ANTIBODY; COLLAGEN TYPE 1 ANTIBODY; COLLAGEN TYPE 3 ANTIBODY; COLLAGEN TYPE 4 ANTIBODY; HLA B27 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; PLACEBO; PULLULANASE; RIFAXIMIN; STARCH; UNCLASSIFIED DRUG;

ANKYLOSING SPONDYLITIS; ANTIMICROBIAL THERAPY; BACTERIAL GROWTH; BACTERIAL IMMUNITY; CROHN DISEASE; CROSS REACTION; DIETARY INTAKE; DRUG EFFICACY; ENVIRONMENTAL FACTOR; ENZYME SYNTHESIS; GENETIC ASSOCIATION; HUMAN; INCIDENCE; INTESTINE FLORA; KLEBSIELLA; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; LOW CARBOHYDRATE DIET; NONHUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS;

EID: 84886543439     PISSN: 16879260     EISSN: 16879279     Source Type: Journal    
DOI: 10.1155/2013/610393     Document Type: Review

References (76)

1. Baumgart D. C., Sandborn W. J., Crohn's disease. The Lancet 2012 380 9853 1590 1605
2. Latella G., Papi C., Crucial steps in the natural history of inflammatory bowel disease. World Journal of Gastroenterology 2012 18 29 3790 3799
3. Baeten D., Breban M., Lories R., Schett G., Sieper J., Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype? Arthritis and Rheumatism 2013 65 1 12 20
4. Ebringer A., Rashid T., 'B27 disease' is a new autoimmune disease that affects millions of people. Annals of the New York Academy of Sciences 2007 1110 112 120 2-s2.0-35748972655 10.1196/annals.1423.013 (Pubitemid 350043001)
5. Ebringer A., Rashid T., Tiwana H., Wilson C., A possible link between Crohn's disease and ankylosing spondylitis via Klebsiella infections. Clinical Rheumatology 2007 26 3 289 297 2-s2.0-33947677664 10.1007/s10067-006-0391-2 (Pubitemid 46486955)
6. Rashid T., Ebringer A., Tiwana H., Fielder M., Role of Klebsiella and collagens in Crohn's disease: a new prospect in the use of low-starch diet. European Journal of Gastroenterology and Hepatology 2009 21 8 843 849 2-s2.0-67651046243 10.1097/MEG.0b013e328318ecde
7. Rashid T., Wilson C., Ebringer A., The link between ankylosing spondylitis, Crohn's disease, Klebsiella and starch consumption. Clinical and Developmental Immunology 2013 2013 9 872632 10.1155/2013/872632
8. Guloksuz S., Wichers M., Kenis G., Depressive symptoms in Crohn's disease: relationship with immune activation and tryptophan availability. PLoS ONE 2013 8 3 e60435
9. Stjernman H., Tysk C., Almer S., Ström M., Hjortswang H., Unfavourable outcome for women in a study of health-related quality of life, social factors and work disability in Crohn's disease. European Journal of Gastroenterology and Hepatology 2011 23 8 671 679 2-s2.0-79960700862 10.1097/MEG.0b013e328346f622
10. Loftus E. V. Jr., Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004 126 6 1504 1517 2-s2.0-2442563304 10.1053/j.gastro.2004.01.063 (Pubitemid 38649869)
11. Molodecky N. A., Soon I. S., Rabi D. M., Ghali W. A., Ferris M., Chernoff G., Benchimol E. I., Panaccione R., Ghosh S., Barkema H. W., Kaplan G. G., Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012 142 1 46.e42 54.e42 2-s2.0-83755219473 10.1053/j.gastro.2011.10.001
12. Yi F., Chen M., Huang M., The trend in newly diagnosed Crohn's disease and extraintestinal manifestations of Crohn's disease in central China: a retrospective study of a single center. European Journal of Gastroenterology and Hepatology 2012 24 12 1424 1429
13. Frolkis A., Dieleman L. A., Barkema H., Environment and the inflammatory bowel diseases. Canadian Journal of Gastroenterology 2013 27 3 18 24
14. Halfvarson J., Genetics in twins with Crohn's disease: less pronounced than previously believed? Inflammatory Bowel Diseases 2011 17 1 6 12 2-s2.0-78650097770 10.1002/ibd.21295
15. Elding H., Lau W., Swallow D. M., Maniatis N., Refinement in localization and identification of gene regions associated with Crohn's disease. American Journal of Human Genetics 2013 92 1 107 113
16. Naser S. A., Arce M., Khaja A., Fernandez M., Naser N., Elwasila S., Thanigachalam S., Role of ATG16L, NOD2 and IL23R in Crohn's disease pathogenesis. World Journal of Gastroenterology 2012 18 5 412 424 2-s2.0-84856689575 10.3748/wjg.v18.i5.412
17. Orchard T. R., Holt H., Bradbury L., Hammersma J., McNally E., Jewell D. P., Wordsworth B. P., The prevalence, clinical features and association of HLA-B27 in sacroiliitis associated with established Crohn's disease. Alimentary Pharmacology and Therapeutics 2009 29 2 193 197 2-s2.0-57649222620 10.1111/j.1365-2036.2008.03868.x
18. Braun J., Bollow M., Remlinger G., Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis and Rheumatism 1998 41 1 58 67 (Pubitemid 28041923)
19. Thjodleifsson B., Geirsson Á. J., Björnsson S., Bjarnason I., A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland. Arthritis and Rheumatism 2007 56 8 2633 2639 2-s2.0-34547742519 10.1002/art.22812 (Pubitemid 47237281)
20. Onderdonk A. B., Richardson J. A., Hammer R. E., Taurog J. D., Correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease. Infection and Immunity 1998 66 12 6022 6023 2-s2.0-0031773073 (Pubitemid 28531869)
21. Kuwahara E., Asakura K., Nishiwaki Y., Inoue N., Watanabe M., Hibi T., Takebayashi T., Effects of family history on inflammatory bowel disease characteristics in Japanese patients. Journal of Gastroenterology 2012 47 9 961 968 2-s2.0-84857460296 10.1007/s00535-012-0558-3
22. Allan R. N., Pease P., Ibbotson J. P., Clustering of Crohn's disease in a Cotswold village. Quarterly Journal of Medicine 1986 59 229 473 478 2-s2.0-0022541105 (Pubitemid 16053368)
23. Aisenberg J., Janowitz H. D., Cluster of inflammatory bowel disease in three close college friends? Journal of Clinical Gastroenterology 1993 17 1 18 20 2-s2.0-0027322041 (Pubitemid 23193771)
24. Li X., Sundquist J., Hemminki K., Sundquist K., Risk of inflammatory bowel disease in first- and second-generation immigrants in Sweden: a nationwide follow-up study. Inflammatory Bowel Diseases 2011 17 8 1784 1791 2-s2.0-79960276599 10.1002/ibd.21535
25. Joossens M., Simoens M., Vermeire S., Bossuyt X., Geboes K., Rutgeerts P., Contribution of genetic and environmental factors in the pathogenesis of Crohn's disease in a large family with multiple cases. Inflammatory Bowel Diseases 2007 13 5 580 584 2-s2.0-34249010216 10.1002/ibd.20086 (Pubitemid 46799642)
26. Peyrin-Biroulet L., Loftus E. V., Colombel J.-F., Sandborn W. J., The natural history of adult crohn's disease in population-based cohorts. American Journal of Gastroenterology 2010 105 2 289 297 2-s2.0-76349114941 10.1038/ajg.2009.579
27. Sonnenberg A., Seasonal variation of enteric infections and inflammatory bowel disease. Inflammatory Bowel Diseases 2008 14 7 955 959 2-s2.0-47949083277 10.1002/ibd.20408
28. Castiglione F., Diaferia M., Morace F., Labianca O., Meucci C., Cuomo A., Panarese A., Romano M., Sorrentini I., D'Onofrio C., Caporaso N., Rispo A., Risk factors for inflammatory bowel diseases according to the "hygiene hypothesis": a case-control, multi-centre, prospective study in Southern Italy. Journal of Crohn's and Colitis 2012 6 3 324 329 2-s2.0-84858075096 10.1016/j.crohns.2011.09.003
29. Roberts-Thomson I. C., Fon J., Uylaki W., Cummins A. G., Barry S., Cells, cytokines and inflammatory bowel disease: a clinical perspective. Expert Review of Gastroenterology and Hepatology 2011 5 6 703 716 2-s2.0-80155182156 10.1586/egh.11.74
30. Brown S. J., Mayer L., The immune response in inflammatory bowel disease. American Journal of Gastroenterology 2007 102 9 2058 2069 (Pubitemid 47301524)
31. Taurog J. D., Richardson J. A., Croft J. T., Simmons W. A., Zhou M., Fernández-Sueiro J. L., Balish E., Hammer R. E., The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. Journal of Experimental Medicine 1994 180 6 2359 2364 2-s2.0-0028003794 10.1084/jem.180.6.2359 (Pubitemid 24351619)
32. Bamias G., Okazawa A., Rivera-Nieves J., Arseneau K. O., De La Rue S. A., Pizarro T. T., Cominelli F., Commensal bacteria exacerbate intestinal inflammation but are not essential for the development of murine ileitis. Journal of Immunology 2007 178 3 1809 1818 2-s2.0-33846493766 (Pubitemid 46154653)
33. Ricanek P., Lothe S. M., Frye S. A., Rydning A., Vatn M. H., Tonjum T., Gut bacterial profile in patients newly diagnosed with treatment-naïve Crohn's disease. Clinical and Experimental Gastroenterology 2012 5 173 186
34. Rashid T., Ebringer A., Gut-mediated and HLA-B27-associated arthritis: an emphasis on ankylosing spondylitis and Crohn's disease with a proposal for the use of new treatment. Discovery Medicine 2011 12 64 187 194 2-s2.0-84859726933
35. Höring E., Göpfert D., Schröter G., von Gaisberg U., Frequency and spectrum of microorganisms isolated from biopsy specimens in chronic colitis. Endoscopy 1991 23 6 325 327
36. Plessier A., Cosnes J., Gendre J.-P., Beaugerie L., Intercurrent Klebsiella oxytoca colitis in a patient with Crohn's disease. Gastroenterologie Clinique et Biologique 2002 26 8-9 799 800 2-s2.0-0036697318
37. Kleessen B., Kroesen A. J., Buhr H. J., Blaut M., Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scandinavian Journal of Gastroenterology 2002 37 9 1034 1041 2-s2.0-0036741464 10.1080/003655202320378220
38. Walmsley R. S., Anthony A., Sim R., Pounder R. E., Wakefield A. J., Absence of Escherichia coli, Listeria monocytogenes, and Klebsiella pneumoniae antigens within inflammatory bowel disease tissues. Journal of Clinical Pathology 1998 51 9 657 661 2-s2.0-0031716014 (Pubitemid 28423723)
39. Schwimmbeck P. L., Yu D. T. Y., Oldstone M. B. A., Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome. Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. Journal of Experimental Medicine 1987 166 1 173 181 2-s2.0-0023182772 (Pubitemid 17101898)
40. Fielder M., Pirt S. J., Tarpey I., Wilson C., Cunningham P., Ettelaie C., Binder A., Bansal S., Ebringer A., Molecular mimicry and ankylosing spondylitis: possible role of a novel sequence in pullulanase of Klebsiella pneumoniae. FEBS Letters 1995 369 2-3 243 248 2-s2.0-0029153311 10.1016/0014-5793(95)00760-7
41. Wilson C., Rashid T., Tiwana H., Beyan H., Hughes L., Bansal S., Ebringer A., Binder A., Cytotoxicity responses to peptide antigens in rheumatoid arthritis and ankylosing spondylitis. Journal of Rheumatology 2003 30 5 972 978 2-s2.0-0037738680 (Pubitemid 36529616)
42. 3 lipopolysaccharide as a potent immunological adjuvant. Microbiology and Immunology 1999 43 1 45 52 2-s2.0-0032904202 (Pubitemid 29056846)
43. 3 lipopolysaccharide as a potent immunological adjuvant. Microbiology and Immunology 1999 43 8 795 801 2-s2.0-0032800579 (Pubitemid 29403889)
44. Ibbotson J. P., Pease P. E., Allan R. N., Serological studies in Crohn's disease. European Journal of Clinical Microbiology 1987 6 3 286 290 2-s2.0-0023355720 10.1007/BF02017614
45. Cooper R., Fraser S. M., Sturrock R. D., Gemmell C. G., Raised titres of anti- Klebsiella IgA in ankylosing spondylitis, rheumatoid arthritis, and inflammatory bowel disease. British Medical Journal 1988 296 6634 1432 1434 2-s2.0-0023918668
46. O'Mahony S., Anderson N., Nuki G., Ferguson A., Systemic and mucosal antibodies to Klebsiella in patients with ankylosing spondylitis and Crohn's disease. Annals of the Rheumatic Diseases 1992 51 12 1296 1300 2-s2.0-0026727051 (Pubitemid 23000064)
47. Tiwana H., Wilson C., Walmsley R. S., Wakefield A. J., Smith M. S. N., Cox N. L., Hudson M. J., Ebringer A., Antibody responses to gut bacteria in ankylosing spondylitis, rheumatoid arthritis, Crohn's disease and ulcerative colitis. Rheumatology International 1997 17 1 11 16 2-s2.0-0030998204 10.1007/PL00006845 (Pubitemid 27239283)
48. Tiwana H., Walmsley R. S., Wilson C., Yiannakou J. Y., Ciclitira P. J., Wakefield A. J., Ebringer A., Characterization of the humoral immune response to Klebsiella species in inflammatory bowel disease and ankylosing spondylitis. British Journal of Rheumatology 1998 37 5 525 531 2-s2.0-0031825177
49. Tiwana H., Natt R. S., Benitez-Brito R., Shah S., Wilson C., Bridger S., Harbord M., Sarner M., Ebringer A., Correlation between the immune responses to collagens type I, III, IV and V and Klebsiella pneumoniae in patients with Crohn's disease and ankylosing spondylitis. Rheumatology 2001 40 1 15 23 2-s2.0-0035146630
50. Flint H. J., The impact of nutrition on the human microbiome. Nutrition Reviews 2012 70 Supplement 1 10 13
51. Scott K. P., Gratz S. W., Sheridan P. O., Flint H. J., Duncan S. H., The influence of diet on the gut microbiota. Pharmacological Research 2013 69 1 52 60
52. Liu J. X., Yue Q. Y., Gao B. Y., Wang Y., Li Q., Zhang P. D., Research on microbial lipid production from potato starch wastewater as culture medium by Lipomyces starkeyi. Water Science and Technology 2013 67 8 1802 1808
53. Cruz B. R., Abraao A. S., Lemos A. M., Nunes F. M., Chemical composition and functional properties of native chestnut starch (Castanea sativa Mill). Carbohydrate Polymers 2013 94 1 594 602
54. Zhang H., Tian Y., Bai Y., Xu X., Jin Z., Structure and properties of maize starch processed with a combination of α -amylase and pullulanase. International Journal of Biological Macromolecules 2013 52 38 44
55. Ali G., Rihouey C., Le Cerf D., Picton L., Effect of carboxymethyl groups on degradation of modified pullulan by pullulanase from Klebsiella pneumonia. Carbohydrate Polymers 2013 93 1 109 115
56. Hii S. L., Tan J. S., Ling T. C., Ariff A. B., Pullulanase: role in starch hydrolysis and potential industrial applications. Enzyme Research 2012 2012 14 921362 10.1155/2012/921362
57. Nakai H., Kitaoka M., Svensson B., Ohtsubo K., Recent development of phosphorylases possessing large potential for oligosaccharide synthesis. Current Opinion in Chemical Biology 2013 17 2 301 309
58. Shanahan F., The colonic microbiota and colonic disease. Current Gastroenterology Reports 2012 14 5 446 452
59. van Laere K. M. J., Hartemink R., Bosveld M., Schols H. A., Voragen A. G. J., Fermentation of plant cell wall derived polysaccharides and their corresponding oligosaccharides by intestinal bacteria. Journal of Agricultural and Food Chemistry 2000 48 5 1644 1652 2-s2.0-0034030164 10.1021/jf990519i (Pubitemid 30331502)
60. Englyst H. N., Macfarlane G. T., Breakdown of resistant and readily digestible starch by human gut bacteria. Journal of the Science of Food and Agriculture 1986 37 7 699 706
61. Anderson I. H., Levine A. S., Levitt M. D., Incomplete absorption of the carbohydrate in all-purpose wheat flour. The New England Journal of Medicine 1981 304 15 891 892 2-s2.0-0019461205 (Pubitemid 11101073)
62. Kleessen B., Stoof G., Proll J., Schmiedl D., Noack J., Blaut M., Feeding resistant starch affects fecal and cecal microflora and short-chain fatty acids in rats. Journal of Animal Science 1997 75 9 2453 2462 2-s2.0-0031228707 (Pubitemid 127446726)
63. Ebringer A., Baines M., Childerstone M., Ghuloom M., Ziff M., Cohen S. B., Etiopathogenesis of ankylosing spondylitis and the cross-tolerance hypothesis. Advances in Inflammation Research-the Spondyloarthropathies 1985 New York, NY, USA Raven Press 101 128
64. McGuire R. G., Hagenmaier R. D., Shellac formulations to reduce epiphytic survival of coliform bacteria on citrus fruit postharvest. Journal of Food Protection 2001 64 11 1756 1760 2-s2.0-0035543226 (Pubitemid 34010093)
65. Paturi G., Nyanhanda T., Butts C. A., Herath T. D., Monro J. A., Ansell J., Effects of potato fiber and potato-resistant starch on biomarkers of colonic health in rats fed diets containing red meat. Journal of Food Science 2012 77 10 216 223
66. Randall C., Vizuete J., Wendorf G., Ayyar B., Constatine G., Current and emerging strategies in the management of Crohn's disease. Best Practice & Research 2013 26 5 601 610
67. Ali T., Kaitha S., Mahmood S., Ftesi A., Stone J., Bronze M. S., Clinical use of anti-TNF therapy and increased risk of infections. Drug, Healthcare and Patient Safety 2013 5 79 99
68. Kouklakis G., Efremidou E. I., Pitiakoudis M., Liratzopoulos N., Polychronidis A. C., Development of primary malignant melanoma during treatment with a TNF- α antagonist for severe Crohn's disease: a case report and review of the hypothetical association between TNF- α blockers and cancer. Drug Design, Development and Therapy 2013 7 195 199
69. Lu K. C., Hunt S. R., Surgical management of Crohn's disease. The Surgical Clinics of North America 2013 93 1 167 185
70. Dewint P., Hansen B. E., Verhey E., Adalmumab combined with ciprofloxacin is superior to adalmumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI). Gut. In press
71. Longmann R. S., Swaminath A., Microbial manipulation as primary therapy for Crohn's disease. World Journal of Gastroenterology 2013 19 10 1513 1516
72. Guslandi M., Rifaximin in the treatment of inflammatory bowel disease. World Journal of Gastroenterology 2011 17 42 4643 4646 2-s2.0-82555168122 10.3748/wjg.v17.i42.4643
73. Khan K. J., Ullman T. A., Ford A. C., Abreu M. T., Abadir A., Marshall J. K., Talley N. J., Moayyedi P., Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. American Journal of Gastroenterology 2011 106 4 661 673 2-s2.0-79953781975 10.1038/ajg.2011.72
74. Prantera C., Lochs H., Grimaldi M., Danese S., Scribano M. L., Gionchetti P., Rifaximin-extended intestinal release induces remission in patients with moderately active crohn's disease. Gastroenterology 2012 142 3 473 481 2-s2.0-84856960246 10.1053/j.gastro.2011.11.032
75. Ebringer A., Wilson C., The use of a low starch diet in the treatment of patients suffering from ankylosing spondylitis. Clinical Rheumatology 1996 15 1 62 66 2-s2.0-0030040424 10.1007/BF02231688
76. Ebringer A., Wilson C., Brostoff J., Challacombe S. J., Ankylosing spondylitis and diet. Food Allergy and Intolerance 2002 London, UK Saunders 761 768